Inventor · disambiguated record
Robert K. Mansfield
Also filed as: MANSFIELD ROBERT · MANSFIELD ROBERT K · MANSFIELD ROBERT KENT
8 granted patents·20 pending applications·47 citations·filing 1978–2023
83Inventor score
Files withCONFORMA THERAPEUTICS CORP6ESTOK THOMAS M5CELGENE INT II SARL3COTHERA BIOSCIENCE INC3LEVI ANDREW E3
Top patents by PatentIndex Score
28 records- 0187US8247423B2Methods and compositions for the treatment of cancer, tumors, and tumor-related disordersESTOK THOMAS M·Filed 2008·Granted Aug 21, 2012·23 cites·24 claims
- 0284US9120815B2Solid state forms of macrocyclic kinase inhibitorsMANSFIELD ROBERT K·Filed 2011·Granted Sep 1, 2015·9 cites·16 claims
- 0377US10544162B2Polymorphic form of TG02ADASTRA PHARMACEUTICALS INC·Filed 2018·Granted Jan 28, 2020·2 cites·20 claims
- 0476US10703760B2Morphic forms of marizomib and uses thereofCELGENE INT II SARL·Filed 2017·Granted Jul 7, 2020·1 cites·14 claims
- 0573US2024254142A1Polymorphic form of tg02 for treating cancerCOTHERA BIOSCIENCE INC·Filed 2023·Application pending·0 cites
- 0673US2024254141A1Polymorphic form of tg02 for treating cancerCOTHERA BIOSCIENCE INC·Filed 2023·Application pending·0 cites
- 0765US11136332B2Morphic forms of marizomib and uses thereofCELGENE INT II SARL·Filed 2020·Granted Oct 5, 2021·0 cites·20 claims
- 0865US2022235063A1Morphic forms of marizomib and uses thereofCELGENE INT II SARL·Filed 2021·Application pending·0 cites
- 0963US2005154751A1System and method for comprehensive management of company equity structures and related company documents with financial and human resource system integrationBOARDROOM SOFTWARE INC·Filed 2004·Application pending·0 cites
- 1061US12043630B2Polymorphic form of TG02 for treating cancerCOTHERA BIOSCIENCE INC·Filed 2020·Granted Jul 23, 2024·0 cites·20 claims
- 1157US2006067953A1Oral pharmaceutical formulations and methods for producing and using sameCONFORMA THERAPEUTICS CORP·Filed 2004·Application pending·0 cites
- 1257US2009293104A1System and method for comprehensive management of company equity structures and related company documents withfinancial and human resource system integrationLEVI ANDREW E·Filed 2009·Application pending·0 cites
- 1357US2009299909A1System and method for comprehensive management of company equity structures and related company documents with financial and human resource system integrationLEVI ANDREW E·Filed 2009·Application pending·0 cites
- 1456US12491160B2Formulations of a farnesoid X receptor agonistLILLY CO ELI·Filed 2021·Granted Dec 9, 2025·0 cites·20 claims
- 1556US2010063020A1Oral pharmaceutical formulations and methods for producing and using sameCONFORMA THERAPEUTICS CORP·Filed 2009·Application pending·0 cites
- 1655US2009238880A1Phospholipid-based pharmaceutical formulations and methods for producing and using sameCONFORMA THERAPEUTICS CORP·Filed 2009·Application pending·0 cites
- 1753US2011106676A1System and method for comprehensive management of company equity structures and related company documents with financial and human resource system integrationLEVI ANDREW E·Filed 2010·Application pending·0 cites
- 1853US2012015919A1Therapies for treating cancer using combinations of cox-2 inhibitors and aromatase inhibitors or combinations of cox-2 inhibitors and estrogen receptor antagonistsESTOK THOMAS M·Filed 2008·Application pending·0 cites
- 1952US2006148776A1Drug formulations having long and medium chain triglyceridesCONFORMA THERAPEUTICS CORP·Filed 2003·Application pending·0 cites
- 2048US2006228405A1Phospholipid-based pharmaceutical formulations and methods for producing and using sameCONFORMA THERAPEUTICS CORP·Filed 2006·Application pending·0 cites
- 2146US4262442ACastle and village making toyMANSFIELD ROBERT·Filed 1978·Granted Apr 21, 1981·12 cites·9 claims
- 2244US2021347736A1Crystalline forms of a farnesoid x receptor agonistMETACRINE INC·Filed 2019·Application pending·0 cites
- 2344US2004024784A1Information system for manipulating data related to the ordering and performance of services and communication of resultsFiled 2003·Application pending·0 cites
- 2443US2011306572A1COMBINATION THERAPY FOR THE TREATMENT OF CANCER USING COX-2 INHIBITORS AND DUAL InHIBITORS OF EGFR [ErbB1] AND HER-2 [ErbB2]ESTOK THOMAS M·Filed 2008·Application pending·0 cites
- 2542US2012052061A1Therapies for treating cancer using combinations of cox-2 inhibitors and anti-her2(erbb2) antibodies or combinations of cox-2 inhibitors and her2(erbb2) receptor tyrosine kinase inhibitorsESTOK THOMAS M·Filed 2008·Application pending·0 cites
- 2641US2013084281A1Methods and compositions for the treatment of cancer, tumors, and tumor-related disordersESTOK THOMAS M·Filed 2012·Application pending·0 cites
- 2740US2007129342A1Compositions Containing AnsamycinCONFORMA THERAPEUTICS CORP·Filed 2006·Application pending·0 cites
- 2838US2016292386A1Systems and architecture for electronic interfaces and complex data structures for medication reconciliation and patient regimen adherence detectionTRUTAG TECH INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Robert K. Mansfield files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →